Condition
Poor Responder
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Unknown3
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT02262923Not ApplicableWithdrawn
Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial
NCT02575924Phase 1UnknownPrimary
Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility
NCT02070198Phase 4Unknown
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
NCT01406600Not ApplicableUnknown
Optimal rhCG(Ovidrel®) Dose in Poor Responder During IVF and ICSI Cycles
Showing all 4 trials